Skip to content
Forge Biologics
  • About
    • About
    • Mission & Approach
    • Leadership
    • Board
  • Services
    • Manufacturing Services
    • Technology
  • Science
    • Science
    • Pipeline
    • About Gene Therapy
    • FBX-101 for Krabbe Disease
  • Careers
  • News & Insights
    • News
    • Events
    • Insights
    • Media Kit
  • Connect

Krabbe Disease

Forge Biologics expanding, leading the way in gene therapy
Gene Therapy CDMO Forges Ahead with $120M Series B Financing
Four Biotechs Rake in Over $350 Million for Rare Diseases, Cancers and More
Gene therapy company secures largest series B financing in Ohio’s history
Drive-backed gene therapy startup raises $120M to amp up biotech manufacturing in Grove City
Gene therapy ‘development engine’ scores $120M to beef up contract manufacturing
Forge Biologics bags $120M round as it looks to scale AAV manufacturing for Krabbe disease treatment
Trial OKed for Rare Disease Gene Therapy
Forge Biologics Cleared for Clinical Trial of FBX-101, a Krabbe Disease Treatment
Copyright Forge Biologics - All Rights Reserved Cookie Notice | Privacy Policy

I agree to the Cookie Notice and Privacy Policy

I agree